Tech Company Financing Transactions
Acumen Pharmaceuticals Funding Round
Acumen Pharmaceuticals, operating out of Charlottesville, secured investment from private investors.
Transaction Overview
Company Name
Announced On
4/27/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
The capital will fund preclinical and potentially early clinical development of ACU-193, which selectively binds to and captures soluble oligomers of the amyloid-beta peptide.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
427 Park St.
Charlottesville, VA 22902
USA
Charlottesville, VA 22902
USA
Phone
Website
Email Address
Overview
Acumen Pharmaceuticals is focused on discovering and developing best in class therapeutics and diagnostics for Alzheimers disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel O'Connell
Chief Medical Officer
Eric Siemers
VP - Regulatory Affairs
Janice Hitchcock
Browse more venture capital transactions:
Prev: 4/27/2013: Scioderm venture capital transaction
Next: 4/29/2013: Ecinity venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs